These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21441624)

  • 1. Endocannabinoid system protects against cryptogenic seizures.
    van Rijn CM; Perescis MF; Vinogradova L; van Luijtelaar G
    Pharmacol Rep; 2011; 63(1):165-8. PubMed ID: 21441624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats.
    Perescis MF; de Bruin N; Heijink L; Kruse C; Vinogradova L; Lüttjohann A; van Luijtelaar G; van Rijn CM
    PLoS One; 2017; 12(2):e0165363. PubMed ID: 28151935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
    Forget B; Barthélémy S; Saurini F; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of milk ingestion and growth after administration of a neutral cannabinoid CB1 receptor antagonist on the first postnatal day in the mouse.
    Fride E; Braun H; Matan H; Steinberg S; Reggio PH; Seltzman HH
    Pediatr Res; 2007 Nov; 62(5):533-6. PubMed ID: 17805201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena.
    Solbrig MV; Adrian R; Baratta J; Piomelli D; Giuffrida A
    Exp Neurol; 2005 Aug; 194(2):355-62. PubMed ID: 16022863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug addiction.
    Justinova Z; Panlilio LV; Goldberg SR
    Curr Top Behav Neurosci; 2009; 1():309-46. PubMed ID: 21104390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk.
    Mach F; Montecucco F; Steffens S
    Pharmacol Rep; 2009; 61(1):13-21. PubMed ID: 19307689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral endocannabinoid system-mediated actions of rimonabant on growth hormone secretion are ghrelin-dependent.
    Al-Massadi O; Gabellieri E; Trujillo ML; Señaris R; Pagotto U; Pasquali R; Casanueva FF; Seoane LM
    J Neuroendocrinol; 2010 Nov; 22(11):1127-36. PubMed ID: 20807320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.
    Wakley AA; Rasmussen EB
    Pharmacol Biochem Behav; 2009 Nov; 94(1):30-6. PubMed ID: 19602424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
    Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-epileptic effects of the cannabinoid receptor antagonist SR141716 in a model of audiogenic epilepsy.
    Vinogradova LV; Shatskova AB; van Rijn CM
    Epilepsy Res; 2011 Oct; 96(3):250-6. PubMed ID: 21733658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.
    Blasio A; Iemolo A; Sabino V; Petrosino S; Steardo L; Rice KC; Orlando P; Iannotti FA; Di Marzo V; Zorrilla EP; Cottone P
    Neuropsychopharmacology; 2013 Nov; 38(12):2498-507. PubMed ID: 23793355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.
    Mukhopadhyay P; Bátkai S; Rajesh M; Czifra N; Harvey-White J; Haskó G; Zsengeller Z; Gerard NP; Liaudet L; Kunos G; Pacher P
    J Am Coll Cardiol; 2007 Aug; 50(6):528-36. PubMed ID: 17678736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid signal in the gut controls dietary fat intake.
    DiPatrizio NV; Astarita G; Schwartz G; Li X; Piomelli D
    Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12904-8. PubMed ID: 21730161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
    Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
    Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
    Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F
    Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: involvement of the endocannabinoid system.
    Perra S; Pillolla G; Luchicchi A; Pistis M
    Alcohol Clin Exp Res; 2008 Mar; 32(3):443-9. PubMed ID: 18215217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rimonabant (Acomplia), specific inhibitor of the endocannabinoid system].
    Ducobu J; Sternon J
    J Pharm Belg; 2005; 60(3):89-91. PubMed ID: 16252510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocannabinoid system: a promising target for the management of type 2 diabetes.
    Scheen AJ
    Curr Protein Pept Sci; 2009 Feb; 10(1):56-74. PubMed ID: 19275673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.
    Xie S; Furjanic MA; Ferrara JJ; McAndrew NR; Ardino EL; Ngondara A; Bernstein Y; Thomas KJ; Kim E; Walker JM; Nagar S; Ward SJ; Raffa RB
    J Clin Pharm Ther; 2007 Jun; 32(3):209-31. PubMed ID: 17489873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.